A genetic polymorphism was identified in the 5?-flanking region of human CYP1A2 gene, and its effect on the transcriptional activation of the CYP1A2 gene was investigated. Nucleotide sequence analysis revealed the existence of a point mutation from guanine (wild type) to adenine (mutated type) at position -2964 in the gene. This point mutation was detected by a polymerise chain reaction-restriction fragment length polymorphism method using DdeI or BslI restriction enzyme, and was proven to be genetically inherited. Allele frequency in 116 Japanese subjects showed 0.77 and 0.23 for the wild and mutated types of allele, respectively.
CYP enzymes play an important role in the metabolism of endogenous and exogenous substrates, including drugs and various chemical carcinogens. CYP1A2 is responsible for the O-deethylation of phenacetin, the 3-demethylation of caffeine, and the metabolic activation of various carcino gens such as 2-aminofluorene, Trp-P-2, and PhIP (1) (2) (3) . Several studies on the CYP1A2-specific metabolism of caffeine in viuo (4) and the microsomal metabolism of phenacetin (5) or caffeine (6) , and the immunodetection of human CYP1A2 protein (3, 5, 7) showed that this enzyme was expressed in the human liver at different levels in different individuals. In fact, large interindividual differ ences in the contents of CYP1A2 mRNA (8) and the capacity to metabolize carcinogens such as 2-acetylamino fluorene, 2-naphthylamine, and 4-aminobiphenyl (9-11) have been reported in humans. These observations suggest 1 This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan. 2Present address: Division of Drug Metabolism, Faculty of Pharma ceutical Sciences, Kanazawa University, Takara-machi 13-1, Kana zawa 920-0934. 3 To whom correspondence should be addressed. E-mail:kamataki @ pharm.hokudai.ac.jp Abbreviations: CYP, cytochrome P450; EM, extensive metabolizer; 3MC, 3-methylcholanthrene; MR, molar ratio; PAH, polycyclic aromatic hydrocarbon; PCR, polymerase chain reaction; PhIP, 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine; PM, poor metab olizer; RFLP, restriction fragment length polymorphism; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; 17X, 1,7-dimethyLxanthine; Trp-P-2, 3-amino-1-methyl-5H-pyrido [4,3- Halogenated hydrocarbons, such as TCDD, and PAHs are potent inducers of CYPs in the CYP1 gene subfamily (12) . The 3MC-responsive region in the human CYP1A2 gene is located as far as about 2.9kb upstream (13) as analyzed by a transient transfection experiment. Recently, positive and negative regulatory cis-elements were reported to exist in the human CYP1A2 gene (from -2352 base to -2094 base) (14) in breast carcinoma MCF-7 cells.
In the present study, we analyzed the nucleotide se quences of the 5?-flanking region of human CYP1A2 gene in Japanese subjects whose CYP1A2 activity had been esti mated by determination of caffeine metabolism. We found a genetic polymorphism in the 5?-flanking region of the CYP1A2 gene, which resulted in decreased induction levels of CYP1A2. Detection of Genetic Polymorphisms in the 5?-Flanking Region-The genotypes of the CYP1A2 gene ascribed to the DdeI and BslI sites in the 5?-flanking region were identified by RFLPs of a PCR-amplified DNA fragment using R2 (5?-GCTACACATGATCGAGCTATAC-3?) and the R3 primers. PCR was performed under the conditions described above. The amplified DNA fragment including the polymorphic site was digested with DdeI or BslI, and subjected to electrophoresis in a 2% agarose gel. 
MATERIALS AND METHODS

Materials
RESULTS
Identification of Polymorphic Mutation in the 5?-Flank ing Region of CYP1A2 Gene-To investigate whether individual differences occurred in the nucleotide sequence of the CYP1A2 gene, the sequence of the 5?-flanking region of the CYP1A2 gene (from -2526 to -3172 base) was analyzed. Genomic DNAs were obtained from two poor metabolizers (PM), who showed the urinary MR [(17U+ 17X)/137X by the caffeine test] of 2.4 and 3.2, and one EM with MR of 13.1 among non-smokers, and from one PM (MR, 1.8) and one EM (MR, 25.1) among smokers. These subjects are typical PMs and EMs, respectively (15) . Four differences in the nucleotide sequence of 5?-flanking region between the present data and the data of Quattrochi and Tukey (13) were found. As a result, replacement of guanine by adenine at position -2964 upstream from the transcrip tional start site was found in two PMs of the five subjects (Fig. 1) . The homozygous wild (guanine type), the homo zygous mutant (adenine type), and the heterozygous mutant were tentatively termed as the w/w, m/m, and w/ m type, respectively. As shown in Fig. 2 , the w/w type genomic DNA having guanine at position -2964 generated a BslI restriction enzyme site, while the m/m type having adenine at the same position produced a DdeI restriction enzyme site. For genotyping of the mutation, PCR-amplifi cation was carried out using the oligonucleotide primers indicated as the R2 and the R3 in Fig. 1 . On DdeI digestion, the amplified DNA fragments from the w/w type gene gave only a single undigested band of 596 bases; the fragments from type m/m gave bands of 464 and 132 bases; type w/ m gave three bands of 596, 464, and 132 bases (Fig. 3) . On BslI digestion, the fragments from the type w/w gene gave bands of 343, 132, 93, and 28 bases; type m/m gave bands of 475, 93, and 28 bases; and type w/m gave five bands of 475, 343, 132, 93, and 28 bases (Fig. 3) . These results were consistent with our sequence analyses shown in Fig. 1 .
To confirm whether the polymorphic mutation was genetically inherited, a family study was performed in Fig. 1 were used for PCR. The amplified DNA fragments were sequenced as described in "MATERIALS AND METHODS." The polymorphic site is shown by arrows.
eight pedigrees of Japanese (data not shown). No discrep ancy was found with the assumption of genetic polymorphism at a single gene locus with autosomal codominant transmission. Allele frequencies in 116 healthy Japanese subjects were 0.77 and 0.23 for the wild and mutated allele, resnectivelv.
As shown in Fig. 1 , other point mutations which differed from the sequence reported by Quattrochi and Tukey (13) were found at the positions -2758, -2756, and -2592 in these five subiects.
Relationship between Genetic Polymorphism of CYP1A2 Gene and Urinary MR of (17U+17X)/137X
in In Vivo Caffeine Metabolism-The urinary MR of (17U+17X)/ 137X was selected for the index of the CYP1A2 activity resulting from the caffeine 3-demethylation activity in a caffeine phenotyping test (4) . The mean MR of (17U+ 17X)/137X was significantly higher (p<0.005) in smokers (11.18±4.60) than in non-smokers (8.63±3.37). The induction of CYP1A2 activity by smoking was consistent with our previous study (15) . To investigate the effect of the mutation at -2964 in the CYP1A2 gene on the inducibility of the CYP1A2 activity, a relationship between MR of the CYP1A2 phenotype and genotype was examined in 66 non-smokers and 50 smokers (Table I ). In non-smokers, the mean MRs in w/w, w/m, and m/m types were 8. 4.56 (n=31), 9.77±4.01 (n=16), and 7.79±5.11 (n=3), respectively. The w/m type and m/m type each showed lower values of the mean MR than the w/w type, but due to the small number of subjects, the difference was not significant. The mean MR was significantly higher (p < 0.05) in w/w type (12.24±4.56) than in non-w/w types (9.46±4.17) in smokers. In w/w type, the mean MR in smokers was significantly higher (p<0.001) than that in non-smokers. On the other hand, no significant difference TABLE I. Relationship between genetic polymorphism at position -2964 in the CYP1A2 gene and the urinary molar ratio of (17U + 17X)/137X in in vivo caffeine metabolism.
a The wild (w) and mutated (m) type have guanine and adenine at position -2964 , respectively. bMR: Urinary molar ratio of (17U+ 17X)/137X in in vivo caffeine metabolism. NS: Not significant . was observed between smokers and non-smokers in non-w/ w types. No relationship between the genotype and the sex or age of subjects was observed (data not shown).
Gel Retardation Analysis of DNA Fragment Containing Polymorphic Site-To investigate the effects of genetic polymorphism in the 5?-flanking region on the transcrip tional regulation of the CYP1A2 gene, we examined if a factor(s) able to bind to this region was present in the nuclear extract of human livers. The results of gel retarda tion analysis with the two types of DNA (type w/w and m/ m) are shown in Fig. 4 . As expected, a factor(s) was present which reacted with each DNA fragment. The formation of a complex with the dDdeW was inhibited by the presence of 100-and 1,000-fold molar excesses of the unlabeled dDdeW competitor, but not by unlabeled dDdeM competi tor. On the other hand, the formation of the complex with the dDdeM was inhibited by the presence of excess amounts of the unlabeled dDdeM competitor, but not by the unlabeled dDdeW competitor (Fig. 4) .
DISCUSSION
Human CYP1A2 is known to be responsible for the metabolic activation of numerous promutagens and carcin ogens. In the present study, we focused on the relationship between the genetic polymorphism of the CYP1A2 gene and the inducibility of CYP1A2. In humans, large interin dividual differences were previously reported in the activ ity of phenacetin O-deethylase (20) , metabolism of carcin ogens such as 2-acetylaminofluorene and 4-aminobiphenyl (9, 11) , and the content of immunoreactive CYP1A2 protein (3, 7) . When a polymorphic locus exists in the regulatory region of a gene, the difference can be explained by a change in the expression level of mRNA. This type of polymorphism in the CYP gene was previously reported in human CYP2E1 (21) . In view of the variation in the content of the CYP1A2 mRNA in unrelated individuals (8) , the interindividual differences in the activity and the content of immunoreactive CYP1A2 are expected to be due to a mutation(s) in the regnlatory region of the gene.
In our previous study, we determined the nucleotide sequences of exon, exon-intron junction, and the 5?-flanking region (up to -2578) of the CYP1A2 gene in several genomic DNA samples from Japanese subjects (15) . Mutations were found which differed from sequences previously reported (8, 13, 22, 23) . In the present study, a novel genetic polymorphism, a point mutation from guanine (type w/w) to adenine (type m/m) at -2964 base, in the 5?-flanking region of the human CYP1A2 gene was found.
Cigarette smoking has been demonstrated to stimulate phenacetin metabolism (24) , increase the amount of im munoreactive CYP1A2 in human liver microsomes (5) , decrease the plasma half-lives of caffeine in vivo (25) , and i ncrease the molar ratio of caffeine metabolites as an index of CYP1A2 activity (15) , indicating that human CYP1A2 is inducible by cigarette smoking . Such evidence that CYP1A2 is induced by smoking was confirmed by the present study. The presence of the mutation significantly decreased the induction of human CYP1A2 by smoking . This is the first report demonstrating the effect of the genetic polymorphism of the CYP1A2 gene on the in vivo transcriptional activation of CYP1A2 .
It was suggested that a 3MC-responsive region in the human CYP1A2 gene was located at about 2 .9 kb upstream of the gene (13) . It is likely that the mutation found in the present study is the same as that reported previously. Cigarette smoking is known to induce CYP1A2 in the human liver as described above, but not in the lung (26, 27) . These data suggest the existence of a liver-specific factor(s) that regulates CYP1A2 expression.
Gel retardation analysis clarified the presence of a factor(s) that reacted with the oligonucleotide probe re gardless of the mutation site. The binding profiles with these oligonucleotide probes differed between the wild and the mutated types, suggesting that the binding of these proteins was specific for each DNA sequence. Since each unlabeled oligonucleotide probe competed in binding of a factor to own oligonucleotide probe, there appear to be at least two factors that bind specifically to the wild and the mutated oligonucleotide. A similar point mutation (adenine to cytosine) in the 5?-flanking region has been reported to human CYP2E1 gene (21) . In the previous report, it was shown that the binding profiles in gel retardation analysis differed between the wild and the mutated types, indicating the possibility of binding of different transcriptional factors to each allele. Hayashi et al. (21) also reported that the mutated allele increases transcription by up to 10-fold. Furthermore, it has been reported that hepatic mRNA content of CYP2E1 in the mutated allele was 3-fold higher than that in the wild type (28) . However, many other studies showed that the mutated allele has no effect (29) (30) (31) . Therefore, the effects of the mutated allele on the expression and the activity of CYP2E1 have been the subject of controversy. In contrast, the present study using in vivo caffeine metabolism indicated that the point mutation in the 5?-flanking region in human CYP1A2 might influence CYP1A2 activity.
It was reported that a region located at -2532/-2423 contained a xenobiotic-responsive element-like sequence that might contribute to the overall induction by 3MC. The induction was observed by the transient transfection of the upstream region of the gene using HepG2 cell line (32) . Recently, cis-elements involved in the positive and nega tive regulations of the CYP1A2 gene have been clarified using breast carcinoma MCF-7 cccccells (from -2352 to -2094) (14) . Thus, the expression of CYP1A2 appears to be regulated by multiple elements including the region shown in the present study.
